Everpure Shares Decline Despite Exceeding Earnings Expectations A Closer Look Deere Company Reports Fiscal Second Quarter 2026 Results BlockCon Punta Cana Web3 iGaming and Finance Industry Leaders to Converge at Caribbean Business Retreat CNBC Portfolio Manager Trims HighFlying Stock After 80 Rally Since April Geopolitical Tensions Escalate Putin Vows Retaliation After Ukraine Strike on Russian Drone Unit Global Leaders Watch Closely as TrumpXi Summit Approaches From Singapore to Brussels CRCT Q1 2026 Earnings EPS Surges Past Estimates with 145 Beat BancFirst Corporation BANF Q1 2026 Earnings Solid EPS Beat Amid Steady Operating Performance Cartesian Therapeutics Inc RNAC Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Ticks Higher ZBIO Q1 2026 Earnings Loss Narrows as EPS Surprises to the Upside TTD Q1 2026 Earnings EPS Misses Estimates Stock Declines JOE Q1 2026 Earnings EPS of 024 Reported Stock Edges Lower Power Solutions International PSIX Holds Steady Near Support Amid Low Volatility Calix Inc CALX Consolidates Near Support as Sector Headwinds Persist WilliamsSonoma WSM Rises 242 as Retail Sector Momentum Drives Stock Above 200 Gabelli Global Small and Mid Cap Value Trust GGZ Edges Higher in Quiet Trading Chevron CVX Slips Over 1 Testing Key Support Levels Amid Sector Headwinds Metas Workforce Reduction Signals Strategic Pivot Toward Artificial Intelligence Nvidia CEO Says Company Has Largely Conceded China AI Chip Market to Huawei Amid Export Restrictions Metas Workforce Reduction Signals Strategic Pivot Toward Artificial Intelligence Acumen Pharmaceuticals Q1 2026 Earnings Narrowed Loss Surprises as Alzheimers Pipeline Advances Chinese AI Firms Zhipu and Minimax Rally on Reports of Potential Hang Seng Index Inclusion SITE Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Billionaire David Einhorn Boosts Victorias Secret Stake Signaling Potential Value in BeatenDown Consumer Stocks POWL Q1 2026 Earnings EPS Misses Estimates Amidst Operational Headwinds Crinetics Pharmaceuticals CRNX Slips 152 as Biotech Sentiment Remains Cautious